Table 1.
Cases of Endophthalmitis after Single Use Vial Intravitreal Injections in the Diabetic Retinopathy Clinical Research Network
| Case | Intravitreal Drug Injected | Culture Results | Povidone-Iodine Use | Pre-op Antibiotics | Post-op Antibiotics |
|---|---|---|---|---|---|
| 1 | Bevacizumab | Coagulase negative staphylococcus | Yes | No | No |
| 2 | Ranibizumab | Coagulase negative staphylococcus | Yes | Yes | Yes |
| 3 | Ranibizumab | Culture negative | Yes | No | Yes |
| 4 | Ranibizumab | Coagulase negative staphylococcus | No* | Yes | Yes |
| 5 | Ranibizumab | Streptococcus viridans† | Yes | No | Yes |
| 6 | Ranibizumab | Coagulase negative staphylococcus | Yes | No | Yes |
| 7 | Masked drug (either saline or ranibizumab) | Culture negative | Yes | No | Yes |
Among 8027 intravitreal injections in the Diabetic Retinopathy Clinical Research Network, this is the only study participant in which injections were performed without use of povidone-iodine, which was considered a protocol deviation. Since this event, the DRCR.net has clarified to participating investigators that no study injections may be performed without use of povidone-iodine over the injection site, even as a protocol deviation.
Scant growth of methicillin resistant staphylococcus aureus also was reported.